GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.
about
GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@en
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@nl
type
label
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@en
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@nl
prefLabel
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@en
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@nl
P2093
P2860
P356
P1433
P1476
GSK-3β phosphorylation-depende ...... colorectal cancer progression.
@en
P2093
Anlong Zhu
Daxun Piao
Guiling Zhu
Niansheng Ren
Qingxin Zhou
Shiqiang Li
Tianyou Liu
Yanwei Xing
Yuekun Zhu
Yuxian Bai
P2860
P304
88599-88612
P356
10.18632/ONCOTARGET.20100
P407
P577
2017-08-09T00:00:00Z